Caber 1 - Pharmaqo Labs

Cabergoline’s side-effect profile is generally mild when used at therapeutic doses, with common side effects including headache, nausea, and lightheadedness. When taken in controlled doses for short-term prolactin suppression, these symptoms are manageable. However, at higher doses or over extended periods, side effects may intensify, necessitating careful monitoring. Hypotension and digestive issues are among the more severe reactions noted at increased doses, requiring supervision by healthcare providers to balance efficacy with safety, especially for patients with sensitive cardiovascular conditions​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Caber 1 by Pharmaqo Labs, consult with your doctor or healthcare professional.